About

EcoR1 Capital is an investment advisory firm focused on the biotech industry. They aim to identify and evaluate innovative therapeutic solutions that can bring significant improvements to patients' lives. Drawing inspiration from the transformative power of the EcoR1 restriction enzyme in the biomedical field, they invest in biotech companies that offer promising new treatments for untreated diseases. EcoR1 Capital recognizes the importance of building upon the innovative contributions of its predecessors in order to continue advancing medical research.

Position in the VCSift Database

  • 33,888 investors in VCSift focus on the fintech sector.
  • 7,285 investors are based in San Francisco, California, United States.

Data sourced from 410,343 investor profiles. Updated July 2026.

Investment Focus

Sectors
fintech biotech

Contact Information

in••••@ecor1cap.com
linkedin.com/in/••••••••

Unlock contact details with a VCSift subscription

Unlock Contact

Already subscribed? Log in

Find more investors like EcoR1

Search Investors